PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsBlueprint Medicines
Blueprint Medicines(BPMC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AyvakitAvapritinib2020-01-092034
Gastrointestinal stromal tumors
AyvakytAvapritinib2020-09-242034
Gastrointestinal stromal tumors
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Avapritinib
neoplasms
,
myeloid leukemia acute
,
hematologic neoplasms
,
mast-cell leukemia
,
central nervous system neoplasms
,
sarcoma
,
neoplasm metastasis
,
recurrence
,
precursor cell lymphoblastic leukemia-lymphoma
,
leukemia
,
myeloid leukemia
,
colorectal neoplasms
,
breast neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
melanoma
,
adenocarcinoma
,
nervous system neoplasms
,
gastrointestinal stromal tumors
,
systemic mastocytosis
,
mastocytosis
Bevifimod
short bowel syndrome
,
syndrome
Sugemalimab
neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
hodgkin disease
,
non-small-cell lung carcinoma
,
lung neoplasms
,
lymphoma
,
small cell lung carcinoma
,
extranodal nk-t-cell lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
carcinoma
,
adenocarcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
analgesia
,
immunotherapy
,
delirium
,
emergence delirium
Sti571
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
Evidence
leukemia
,
neoplasms
,
myeloid leukemia acute
,
myeloid leukemia
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
,
lung neoplasms
,
non-small-cell lung carcinoma
,
small cell lung carcinoma
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
lymphoma
,
adenocarcinoma
,
sarcoma
,
pancreatic neoplasms
,
central nervous system neoplasms
,
colorectal neoplasms
,
head and neck neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
depression
,
depressive disorder
,
hereditary breast and ovarian cancer syndrome
,
triple negative breast neoplasms
,
bipolar disorder
,
hypercholesterolemia
,
esophagitis
,
biliary tract neoplasms
,
fallopian tube neoplasms
,
systemic lupus erythematosus
,
chronic obstructive pulmonary disease
,
asthma
,
type 2 diabetes mellitus
,
heart failure
,
diabetes mellitus
,
hemorrhage
,
myocardial infarction
,
infarction
,
eosinophilia
,
pulmonary eosinophilia
,
urologic neoplasms
,
major depressive disorder
,
peptic ulcer
,
gastrointestinal hemorrhage
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
second primary neoplasms
,
gene fusion
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
multiple pulmonary nodules
,
solitary pulmonary nodule
,
percutaneous coronary intervention
,
inferior wall myocardial infarction
,
mental disorders
,
pregnancy
,
urinary bladder neoplasms
,
invasive hydatidiform mole
,
non-muscle invasive bladder neoplasms
,
metabolic diseases
,
metabolic bone diseases
,
osteoporosis
,
osteoporotic fractures
,
obstructive lung diseases
,
systolic heart failure
,
cardiovascular diseases
,
heart diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use